Interactions in Diabetes is an authoritative and innovative resource tool for Key Opinion Leaders in diabetes – stay up to date with the latest clinical data surrounding Linagliptin, a novel DPP4-inhibitor, and its value in the type 2 diabetes mellitus treatment (T2DM) continuum.
Interactions in Diabetes incorporates an ingenious Presentation Builder function for users to craft the Linagliptin story to their presentation needs. Simply log in to Interactions in Diabetes to access a comprehensive library of subject categories pertinent to the Linagliptin story. Each subject category comprises of fully referenced slide decks that are easy to understand, come complete with notes, and are fully downloadable. Users can also upload external slides onto Interactions in Diabetes to create a truly personal diabetes resource database.
Interactions in Diabetes – the latest Linagliptin information at the touch of a button. less
|
